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Cell cycleRheum emodi (Polygonaceae), amultipurposemedicinal herb is a rich repository of pharmacologically active sec-
ondarymetabolites known as anthraquinones. The present study entails HPLC quantitation and in vitro activity of
four major constituents and the extracts of R. emodi. The anthraquinone glycosides were more abundant than
their aglycone constituents viz. emodin and chrysophanol. MTT assay was used to assess the in vitro antiprolifer-
ative activity of anthraquinones and extracts on four cancer cell lines namely MIAPaCa-2, HCT-116, MCF-7 and
T47D. The cytotoxicity was more obvious on MIAPaCa-2. Further, the study of mechanism of action involving
cell cycle analysis and determination of mitochondrial membrane potential (MMP) loss was also investigated.
The extracts signiﬁcantly reduced cell viability by inducing apoptosis/necrosis and cell cycle arrest with concur-
rent loss of MMP (Δψm) in a concentration dependent manner. The methanolic extract of rhizome (SPL5) with
the least IC50 value (25 μg/ml) showed a signiﬁcant increase in the percentage of apoptotic/necrotic cells (42.3%
at 100 μg/ml) compared to that of vehicle treated cells (11.6%). These cellular manifestations corresponded re-
markably with a decrease in the integrity of the mitochondrial membrane. In conclusion, SPL5 with emodin
and chrysophanol as the preponderant constituents exhibited considerable antiproliferative activity possibly
by reducing cell viability and stirring up Δψm loss.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
The clonal disorder, cancer, is a diverse class of complex diseases
which differ widely in their cause and biology. It is a pathological condi-
tion that involves upregulation of certain oncogenic signaling pathways
that prop up proliferation, hold back apoptosis, and allow themalignan-
cy to spread and trigger angiogenesis. Cancer, identiﬁed by the WHOCa-2, pancreatic cancer cell line
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health and development, is the leading cause of deaths across the
world. In the United States alone, one in four deaths is due to cancer
(Siegel et al., 2013). As per the new version of IARC's (International
Agency for Research on Cancer) database GLOBOCAN about 12.7million
new cancer cases occurredworldwide in 2008 that accounted for 14% of
all deaths, with breast and colorectal cancers sharing themajor propor-
tion (Jemal et al., 2011). Moreover, pancreatic cancer is one of the most
malignant and aggressive forms of cancer (Li et al., 2004). It is the fourth
most common cause of cancer-related deaths in the United States and
the eighth worldwide (Hariharan et al., 2008).
Plants have been used as medicine since antiquity probably from
middle Paleolithic age some 60,000 years ago (Solecki, 1975). As per
the estimation of the WHO about 75% of the population of Asian and
African countries still relies on conventional and traditional methods
for the treatment of various diseases (Wani et al., 2013). These preven-
tivemeasuresmostly involve the use of herbal extracts which are cheap
and comparatively offer high safety and lesser side effects. The tradi-
tionally observed gamut of pharmacological efﬁcacy in competent herb-
al medicine may only arise because of the synergistic action of multiple
Table 1
Places of collection of different samples of R. emodi.
Location
code
Location Geographic co-ordinate
1 Bonera Farm, Pulwama,
Kashmir
33° 52′ 59″ N, 74° 55′ 00″ E;
1630 m asl
2 Yarikhah Farm, Gulmarg,
Kashmir
34° 04′ 797″ N, 74° 26′ 448″ E;
2119 m asl
3 Pense La Top, Ladakh 33° 51′ 08″ N, 76° 21′ 57″ E;
4287 m asl
4 Nyoma Valley, Ladakh 33° 08′ 661″ N, 78° 34′ 742″ E;
4415 m asl
2 S.A. Pandith et al. / South African Journal of Botany 95 (2014) 1–8ingredients. In the last few decades, the plant derived natural products
have found their use as efﬁcient chemotherapeutic and/or chemopre-
ventive agents for the effective treatment of vast diversity of cancers.
Despite topical advances in our understanding of the biological process-
es leading to the development of cancer, there is still a need for new and
effective agents to bring cancer under control. Phytomedicine offers a
great deal to the health system as presently about 25% of the pharma-
ceutical prescriptions in the United States contain at least one plant-
derived ingredient. Based on the traditional knowledge around 121
pharmaceutical products were formulated in the last century (Pandey
et al., 2011). The metabolomes of medicinal plants serve as a valuable
natural resource for pharmaceuticals and provide a room for renewed
attention from both practical and scientiﬁc viewpoints for the evidence
based development of new phytotherapeutics and nutraceuticals.
Rheum (Rheum emodiWall. Ex. Meissn. Syn: Rheum australe D. Don.,
Polygonaceae) is an endemic, robust, perennial, diploid (n = 11; 2×)
medicinal and vegetable herb distributed in the temperate and subtrop-
ical regions of the Himalayas from Kashmir to Sikkim, at elevations
ranging from2000 to 4500m. The plant has dark reddish-purpleﬂowers,
in dense branched clusters in a long inﬂorescence which can be 1 ft long.
The stems are stout, streaked green and brown, and 1.5–2mhigh. Plants
propagate either by seeds or by rootstock. R. australe is commonly
known as Himalayan rhubarb or red-veined pie plant in English and
pumbachalan in Kashmiri. It is native to India, Myanmar, Nepal,
Pakistan and Sikkim. R. emodi ﬁnds an extensive use in Ayurvedic and
other traditional medical systems, like homeopathic, Tibetan, Unani
and Chinese systems (Bhatia et al., 2011). Extracts from the roots,
bark and leaves of rhubarb have been used as a laxative since ancient
times and presently are widely used in various herbal preparations
(Wang et al., 2007). The major phytoconstituents reported from the
plant include anthraquinones (emodin, aloe-emodin, chrysophanol,
rhein, physcion) and stilbenes, and their respective glycoside deriva-
tives. These frequently occurring key constituents are reportedly
known for various biological activities including antioxidant, cytotoxic,
antimicrobial, antifungal, antitumor, antidiabetic, antiproliferative and
immunoenhancing (Zargar et al., 2011). Emodin is a selective casein ki-
nase II inhibitor which competitively binds to the ATP binding pocket of
the kinase (Fullbeck et al., 2005). In human cancer cells emodin inhibits
TPA-induced cell invasiveness andMMP-9 expression through suppres-
sion of bothAP-1 andNF-κB signaling pathways (Huang et al., 2004). In-
creasing focus is being directed towards alternative types of cell death
like autophagy, mitotic catastrophe and necrosis. The clear understand-
ing about the molecular events leading to cell death can facilitate to-
wards a more rational approach for anticancer treatments (de Bruin
and Medema, 2008). The major anthraquinones with the exception of
chrysophanol have been shown to induce apoptosis in various animal
and human cancer cell lines. Chrysophanol stimulated ROS production,
mitochondrial dysfunction, loss of ATP and DNA damage in J5 human
liver cancer cells which ﬁnally lead to necrotic cell death (Lu et al.,
2010).
About 60% of the approved drugs for treatment and prevention of
cancer have their origin from natural sources (Gul et al., 2013). Nature
has provided various potent antitumor agents like microbial derived
drugs such as bleomycin, doxorubicin and dactinomycin. There are
also plant based drugs like vincristine, vinblastine, irinotrecan,
topotecan, etoposide and paclitaxel with wide pharmacological signiﬁ-
cance. In the last few decades robust evidences from in vivo and
in vitro studies by using human normal and malignant cells indicate
that plant extracts protect against various cancers. Presently natural
products continue to offer a fabulous range of lead structures, which
act as a source for the development of new drugs (Abdullaev, 2001).
Furthermore, plant natural products and scaffolds hold promise to de-
sign new and potent multi-target drugs and drug combinations that
are efﬁcacious for the treatment of various human ailments. In the
present study we attempted to explore the in vitro antiproliferative ac-
tivities of four major anthraquinones and of the methanolic and ethyl-acetate herbal extracts from the rhizome and leaves of R. emodi. The di-
versity in concentration of key chemical/bioactive constituents of plant
samples collected from four different geographic locations of North
Western Himalayas with an altitudinal range of 1600 m to 4500 m
was also determined by a slightly modiﬁed standard HPLC method.2. Materials and methods
2.1. Plant material
The plant samples of R. emodiwere collected from four different lo-
cations of Kashmir Himalayas (Jammu and Kashmir State, India) in the
months of June–July 2012. The located geographic zones are spread
over an altitudinal range of 1600 to 4500m (Table 1). The plantmaterial
waswell identiﬁed and further authenticated byDr. S. N. Sharma, Senior
Technical Ofﬁcer, Janaki Ammal Herbarium, Indian Institute of Integra-
tive Medicine (CSIR), Jammu, India. A voucher specimen (RRL-22175)
has been preserved for future reference in the Herbarium.2.2. Chemicals
DMSO, RPMI-1640, DMEM, penicillin G and streptomycin were pur-
chased from Sigma Aldrich, St. Louis, USA. Fetal bovine serum (FBS),
phosphate buffered saline (PBS), propidium iodide and rhodamine-
123 were obtained from Merck, Darmstadt, Germany. All other
chemicals and solvents used were of analytical and HPLC grade. Fresh
ultra-pure distilled water with resistivity greater than 18MΩwas used.2.3. Pure compounds
Pure standards of two major anthraquinones namely emodin and
chrysophanol were purchased from Sigma Aldrich (St. Louis, USA) and
their respective glycosides; emodin glycoside and chrysophanol glyco-
side (Fig. 1) were obtained from the Institute of Himalayan Bioresource
Technology, Palampur, India (kindly provided by A. K. Sinha). Their pu-
rities were above 99% as determined by HPLC analysis.2.4. Extraction procedure
Plant samples of R. emodi collected from four different Himalayan
locations were chopped, properly cleaned and completely dried
under gentle air stream (temperature 25 ± 2 °C and relative humidity
65 ± 5%). The leaves as well as the rhizomes of all these plant samples
were ground separately into ﬁne powder with a mortar and pestle. The
powdered rhizomes (50 g of each sample) and leaves (20 g of each sam-
ple) of different samples were serially extracted eachwith methanol (3
× 250 ml) and ethyl-acetate (3 × 200 ml) using Soxhlet apparatus. The
extracts were ﬁltered through a Whatman No. 1 paper ﬁlter and sol-
vents were removed under reduced pressure using a rotary evaporator,
and then kept at 4 °C until use.
Fig. 1. Chemical structures of emodin (A), chrysophanol (B), emodin glycoside (C) and chrysophanol glycoside (D).
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The stock solutions (1 mg/ml) of each of the four anthraquinones
were freshly prepared in a mixture of methanol:acetonitrile (80:20,
v/v). Similarly, the crude extracts of all the leaves and rhizomes of col-
lected plant samples were also dissolved in the same solvent composi-
tion (20 mg/ml) and were ﬁlter sterilized with 0.25 μm membrane
ﬁlters (Millipore, Bedford, USA). The HPLC (Shimadzu CLASS-VP V
6.14 SPI model) equipped with RP-18e column (E-Merck, 5 μm, 4.6
× 250 nm), a photo-diode array detector (SPD-M10A VP model) and a
pump (LC-10AT VP model) was used for the analysis of the
anthraquinones. Acetonitrile:methanol (95:5, v/v) (solvent B) and
water:acetic acid (99.9:0.1, v/v, pH 3.5) (solvent A) were used as a mo-
bile phase with a linear gradient elution as follows: 0–15 min, 20% B;
15–25 min, 20% B; 25–30 min, 50% B; 30–40 min, 70% B; 40–45 min,
100% B; 45–50 min, 20% B; and 50–55 min, 20% B; at a ﬂow rate of
0.8 ml/min. The detectionwavelengthwas set at 254 nm. Injection vol-
ume of the sample was 10 μL and the column temperature was 30 °C.
2.6. Detection and quantiﬁcation of anthraquinones
Identiﬁcation and quantiﬁcation of anthraquinones were accom-
plished using a reverse-phase HPLC at a set wavelength of 254 nm.
The detectionwasmade on the basis of retention timeof reference com-
pounds under a speciﬁc set of column operating conditions. Elution po-
sitions were established with authentic samples and by comparison
with literature data. Relative contents of different anthraquinone con-
stituents were determined and expressed as percentage peak area.
The HPLC chromatograms of all the screened samples are depicted in
Fig. S1–S7.
2.7. Cell lines and culture conditions
MCF-7 and T47D (breast), HCT-116 (colon), and MIAPaCa-2 (pan-
creas) cells were routinely maintained in Dulbecco's Modiﬁed Eagle's
Medium (DMEM) while fR2 (normal epithelial) cells were maintained
in Roswell Park Memorial Institute-1640medium (RPMI-1640) supple-
mented with 10% fetal bovine serum (FBS) and 1% penicillin G and
streptomycin at 37 °C in a humidiﬁed incubator with 5% CO2. All stock
solutions of the samples were prepared in cell culture grade dimethyl
sulfoxide (DMSO) and stored at−20 °C. The samples were diluted in
culture media prior to their use in experiments.2.8. MTT cell viability assay
The different crude extracts of plant samples and four of the second-
ary metabolite constituents namely emodin (SPL1), chrysophanol
(SPL2), emodin glycoside (SPL3) and chrysophanol glycoside (SPL4)
were subjected to antiproliferative assay against four cancer cell lines
viz. MCF-7, T47D, HCT-116, and MIAPaCa-2 and a normal epithelial
cell line, fR2. All the selected samples were dissolved in cell culture
gradeDMSObefore screening. Cell viability of the treated cellswasmea-
sured by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) assay. Brieﬂy, cells (104 cells/well) were cultured in
96 well tissue culture plates and treated with different concentrations
of compounds for 48 h. At the end of incubation, 20 μL of MTT
(2.5 mg/ml) was added to the wells and incubated for 4 h. Absorbance
was recorded at 570 nm using Eliza Plate Reader.2.9. Cell cycle analysis by propidium iodide (PI) staining
After 24 h of incubation, to exponentially growing MIAPaCa-2 cells
(2 × 105 cells/ml/well) 10, 50 and 100 μg/ml of extracts SPL-5, 6, 7
and 8 were added and incubated further for 48 h. Control cells were
treated onlywith vehicle DMSO (b0.5%). Both control and extract treat-
ed cellswere harvested by trypsin treatment, washed in cold PBS (phos-
phate buffer saline), ﬁxed with 70% ethanol for about 48 h at−20 °C
and again washed with cold PBS. In order to remove RNA, the cells
were treated with 40 μg of RNase for 1 h and 30 min at 37 °C followed
by staining with 5 μg of PI (propidium iodide) at RT in the dark for
20min before analyzing by FACS Aria II ﬂow cytometer (BD Biosciences,
San Jose, USA).2.10. Mitochondrial membrane potential (MMP) assay
The human pancreatic cancer cell line, MIAPaCa-2, was seeded into
6-well culture plate (2 × 105 cells/ml/well) and incubated overnight.
Different concentrations of extracts SPL5, SPL6, SPL7 and SPL8 (10, 50
and 100 μg/ml) were added to the cells and incubated for 48 h. 1 h be-
fore the completion of 48 h treatment, rhodamine-123 (Rh-123) was
added at a concentration of 1 μMto eachwell. The cellswere trypsinized
and washed in PBS once. The cell pellets were resuspended in 500 μL of
PBS and analyzed using a FACS Aria II ﬂow cytometer for detecting the
mitochondrial depolarization patterns.
Fig. 2. Anthraquinone concentrations in extracts. a) graph depicting concentration of
major anthraquinones in methanolic extracts of rhizomes; b) in ethyl-acetate extracts of
rhizomes; and c) in methanolic and ethyl-acetate leaf extracts. BNRM, YKRM, PLRM and
NVRM are the methanolic rhizome extracts from locations 1, 2, 3, and 4 respectively;
BNRE, YKRE, PLRE and NVRE are ethyl-acetate rhizome extracts from locations 1, 2, 3
and 4 respectively; PLLM, NVLM and PLLE, NVLE aremethanolic and ethyl-acetate leaf ex-
tracts from locations 3 and 4 respectively. All values obtained were means of triplicate
with standard error.
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The scope of the present investigation extends towards the evalua-
tion of in vitro cytotoxic potential of herbal extracts of R. emodi along
with their known key chemical constituents, namely anthraquinones.
It entailed the evaluation of the cytotoxic response of MIAPaCa-2 upon
exposure to crude extracts to elucidate the mechanism of action by
employing cell cycle analysis and MMP assay. Another important aim
of this study was to identify elite chemotypes with desirable chemical
proﬁles for pharmaceutical and commercial purposes. The metabolite
accumulation is an efﬁcient strategy mainly adopted by plants to thrive
across diverse habitats under the umbrella of different kinds of biotic
and abiotic conditions of stress. The interesting differences in the con-
centration ofmajor bioactive phytoconstituentswithin the same species
across an altitudinal gradient with varying temperature ranges present
a differential and signiﬁcant perspective for their potential use in mod-
ern medicine. This study also provides an outlook to explore desirable
populations of R. emodi with higher contents of chemical constituents
for pharmacological applications.
3.1. Determination of major anthraquinone constituents
Various methods for the identiﬁcation and quantiﬁcation of anthra-
quinone derivatives have been reported previously. However, so far
there has been no such comprehensive study undertaken that involves
locational comparison in anthraquinone concentrations in rhizome as
well as leaf samples of R. emodi across the altitudinal gradient of North
Western Himalayas ranging from 1600 to 4500 m (Table 1). The stan-
dard HPLC method with slight modiﬁcations was employed to deter-
mine the concentrations of major anthraquinones (Verma et al.,
2005). The results showed interesting differences in the content of an-
thraquinone constituents. Tissue-speciﬁc chemoproﬁling revealed pre-
ponderance of anthraquinones and their glycosides in rhizomes in
comparison to leaves.
The methanolic extracts of the rhizomes showed the highest con-
centration out of the four chemical constituents at the highest altitude
in Nyoma Valley (Ladakh). Here, the concentration of emodin and
chrysophanol averaged 24.569±0.91mg/g and 54.512±1.95mg/g re-
spectively. The mean values for their respective glycosides were
128.328± 4.83mg/g and 76.305± 3.07mg/g (Fig. 2a; Table 2). The in-
creased levels of anthraquinones at higher altitudes are in conformity
with the previous reports wherein it has been shown that an increase
in secondary metabolite content is positively correlated with altitude
(Farooq et al., 2013). However, ethyl-acetate extracts of rhizomes
showed the reverse trend, wherein anthraquinone constituents showed
maximum accumulation except for chrysophanol at Bonera location.
Here, the maximum recorded concentrations for emodin and
chrysophanol were 14.535 ± 0.86 mg/g and 39.939 ± 1.40 mg/g and
for their respective glycosides they averaged 211.952 ± 8.39 mg/g
and 74.427 ± 1.61 mg/g, respectively (Fig. 2b; Table 2). A similar de-
creasing trend, with increasing altitude, in concentrations of major an-
thraquinones was observed in both methanolic and ethyl-acetate
extracts of leaf samples (Fig. 2c; Table 2). A similar trend in the pattern
of secondary metabolite accumulation has previously been reported in
Lupinus argenteus also (Carey and Wink, 1994).
The enormous diversity of bioactive constituents in plants are pri-
marily derivatives of few biochemical motifs for undertaking various
functions in the operating metabolic circuits. One of the important dec-
orations is through glycosylation which is related to speciﬁc plant func-
tions like xenobiotic detoxiﬁcation, regulation of hormone homeostasis,
and biosynthesis and storage of important phytoconstituents and
shows its widespread occurrence in plants. Among the four anthra-
quinones quantiﬁed, the overall concentration of glycosides was
found to be higher than those of their respective aglycone forms in
all the extracts across the altitudinal gradients (Fig. 2; Table 2).
This shufﬂe of anthraquinones in the direction of glycosylation, likemany other plant natural products may be towards increasing solu-
bility and stability for facilitating their easy storage and accumula-
tion in plant cells.
3.2. Antiproliferative activity
The standards as well as the rhizome and leaf-speciﬁc extracts were
evaluated for their in vitro anticancer activity against four cell lines at
three different concentrations viz. 100, 50, 10 μMfor standardmolecules
Table 2
Concentrations of major anthraquinone constituents from plant samples collected from four different geographical locations of North Western Himalayas.
Location code Emodin (mg/g DWBa) Chrysophanol (mg/g DWB) Emodin glycoside (mg/g DWB) Chrysophanol glycoside (mg/g DWB)
BNRM 2.273 ± 0.056 0.0098 ± 0.0021 34.617 ± 1.278 30.579 ± 1.469
YKRM 3.543 ± 0.318 15.896 ± 0.556 92.229 ± 3.428 34.681 ± 1.435
PLRM 2.224 ± 0.329 8.33 ± 0.439 82.61 ± 3.005 5.578 ± 0.399
NVRM 24.569 ± 0.909 54.512 ± 1.952 128.328 ± 4.835 76.305 ± 3.074
BNRE 14.535 ± 0.867 31.33 ± 1.265 211.952 ± 8.399 74.427 ± 1.613
YKRE 0.416 ± 0.019 0.957 ± 0.0216 27.674 ± 1.261 3.611 ± 0.357
PLRE 7.651 ± 0.480 29.403 ± 0.995 90.683 ± 3.363 13.256 ± 0.571
NVRE 4.552 ± 0.331 39.939 ± 1.402 5.396 ± 0.467 0.305 ± 0.0106
PLLM 4.42 ± 0.296 0.146 ± 0.0087 31.613 ± 1.416 1.877 ± 0.054
NVLM 0.013 ± 0.00037 0.059 ± 0.00139 0.325 ± 0.0118 0.295 ± 0.014
PLLE 4.617 ± 0.4019 0.166 ± 0.0093 27.279 ± 0.774 1.444 ± 0.049
NVLE 0.111 ± 0.0074 0.214 ± 0.0079 0.594 ± 0.0158 0.479 ± 0.012
a Dry weight basis.
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tor, was used as positive control (0.01 μM) because most of the cancer
cell lines used have PI3K mutations. The half maximal inhibitory con-
centration (IC50), a measure of the effectiveness of a compound in
inhibiting some speciﬁc biological or biochemical function was used as
a parameter of cytotoxicity. The percentage growth inhibition for stan-
dard molecules and extracts including their IC50 values against variousTable 3
Percentage growth inhibition at 100, 50, 10 μM for standard molecules (SPL1, SPL2, SPL3 and S
against breast cancer cell lines (MCF-7, T47D), colon cancer cell line (HCT-116), pancreatic ca
(0.01 μM) was used as positive control. Values are means of three replicates ± SD.
Tissue type Breast
Cell type MCF-7 T4
S. no Code Conc. % growth inhibition
1 SPL1 100 μM 26 ± 1.98 15
50 μM 18 ± 0.97 10
10 μM 13 ± 1.85 10
IC50 N100 μM N1
2 SPL2 100 μM 32 ± 0.02 21
50 μM 27 ± 1.05 16
10 μM 26 ± 2.04 3 ±
IC50 N100 μM N1
3 SPL3 100 μM 15 ± 1.02 25
50 μM 14 ± 0.01 19
10 μM 11 ± 0.03 18
IC50 N100 μM N1
4 SPL4 100 μM 26 ± 0.01 42
50 μM 19 ± 0.01 25
10 μM 9 ± 0.87 15
IC50 N100 μM N1
5 SPL5 100 μg/ml 40 ± 1.02 38
50 μg/ml 32 ± 0.01 22
10 μg/ml 1 ± 0.04 3 ±
IC50 N100 μg/ml N1
6 SPL6 100 μg/ml 50 ± 1.01 50
50 μg/ml 33 ± 2.88 31
10 μg/ml 2 ± 0.01 6 ±
IC50 N100 μg/ml N1
7 SPL7 100 μg/ml 50 ± 1.02 37
50 μg/ml 35 ± 1.01 22
10 μg/ml 2 ± 0.01 13
IC50 100 μg/ml N1
8 SPL8 100 μg/ml 57 ± 2.01 13
50 μg/ml 42 ± 3.04 28
10 μg/ml 10 ± 0.02 3 ±
IC50 77 μg/ml N1
Control BEZ-235 10 nM 37 ± 2.94 36cell lines are depicted in Table 3. The extracts SPL5 (methanolic extract
of rhizome) and SPL8 (ethyl-acetate extract of leaf) were found to be
most active with an IC50 value range of 40–41 μg/ml in the case of
HCT-116 and 25–34 μg/ml in MIAPaCa-2 compared to control, fR2
(43–45 μg/ml). Further, none of the extracts were found to be effective
against any of the breast cancer cell lines,with IC50 values of 77 μg/ml or
more (Fig. 3a, b; Table 3). The cytotoxicity ratio of normal (fR2) toPL4) and 100, 50, 10 μg/ml for extracts (SPL5, SPL6, SPL7 and SPL8) and their IC50 values
ncer cell line (MIAPaCa-2) and normal epithelial cell line (fR2) with MTT assay. BEZ-235
Colon Pancreatic Normal epithelial
7D HCT-116 MIAPaCa-2 fR-2
± 0.87 38 ± 2.10 56 ± 1.93 65 ± 2.85
± 0.86 17 ± 2.02 40 ± 1.02 38 ± 2.05
± 1.89 4 ± 0.01 4 ± 1.01 3 ± 2.03
00 μM N100 μM 82 μM 72 μM
± 1.01 22 ± 0.08 59 ± 3.02 65 ± 0.02
± 2.79 10 ± 1.87 44 ± 1.88 43 ± 1.03
0.01 5 ± 2.05 35 ± 2.11 14 ± 0.94
00 μM N100 μM 70 μM 70 μM
± 1.86 26 ± 3.02 11 ± 1.02 11 ± 1.01
± 0.95 17 ± 0.85 9 ± 1.04 6 ± 0.02
± 1.03 10 ± 0.92 7 ± 1.01 4 ± 0.11
00 μM N100 μM N100 μM N100 μM
± 2.04 10 ± 1.09 37 ± 1.96 20 ± 0.89
± 1.03 8 ± 2.06 28 ± 1.01 13 ± 0.87
± 3.01 1 ± 0.01 10 ± 0.99 6 ± 0.01
00 μM N100 μM N100 μM N100 μM
± 1.02 77 ± 2.03 83 ± 1.93 65 ± 1.01
± 1.04 63 ± 0.91 80 ± 1.02 61 ± 0.94
0.86 6 ± 0.94 32 ± 0.89 1 ± 0.96
00 μg/ml 41 μg/ml 25 μg/ml 43 μg/ml
± 1.79 79 ± 1.01 78 ± 2.04 71 ± 0.97
± 1.93 55 ± 1.99 73 ± 3.01 66 ± 1.03
1.01 1 ± 0.01 27 ± 2.02 2 ± 1.01
00 μg/ml 46 μg/ml 37 μg/ml 40 μg/ml
± 1.05 77 ± 2.02 80 ± 0.88 73 ± 1.03
± 0.02 58 ± 0.01 77 ± 1.03 63 ± 0.94
± 0.88 7 ± 0.94 25 ± 1.06 10 ± 0.01
00 μg/ml 44 μg/ml 29 μg/ml 40 μg/ml
± 0.98 73 ± 1.93 74 ± 2.11 65 ± 0.89
± 1.86 64 ± 2.78 70 ± 1.01 55 ± 1.86
1.01 4 ± 1.03 20 ± 1.02 11 ± 2.04
00 μg/ml 40 μg/ml 34 μg/ml 45 μg/ml
± 4.94 34 ± 3.77 43 ± 2.03 58 ± 0.01
Fig. 3.MTT assay. a) Comparison of IC50 values of standard molecules (SPL1, SPL2, SPL3
and SPL4); and b) extracts (SPL5, SPL6, SPL7 and SPL8) against breast cancer cell lines
(MCF-7, T47D), colon cancer cell line (HCT-116), pancreatic cancer cell line (MIAPaCa-2)
and normal epithelial cell line (fR2). SPL1, emodin; SPL2, chrysophanol; SPL3, emodin gly-
coside; SPL4, chrysophanol glycoside; SPL5, methanolic rhizome extract; SPL6, rhizome
ethyl-acetate extract; SPL7,methanolic leaf extract; SPL8, leaf ethyl-acetate extract. Values
are means of thee replicates ± SD.
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pared to that of SPL6 (1.08), SPL7 (1.38) and SPL8 (1.32). The higher cy-
totoxic ratio of SPL5 may confer it with a better possible role in
antiproliferative activity.
Since MIAPaCa-2, the human pancreatic cancer cell line was chieﬂy
sensitive to the crude extracts used for elucidating the cytotoxic effects,
further studies were carried out with this cell line. To the best of our
knowledge, anthraquinones from R. emodi have not been tested on
pancreatic tumors, especially on MIAPaCa-2, a solid pancreatic
tumor cell line. The results possibly indicate towards the existence
of a synergistic effect of crude extracts as they were more potent in in-
ducing cell death than the individual chemical compounds viz. emodin
and chrysophanol.3.3. Mechanisms involved in cytotoxicity
The desirable cytotoxic response of MIAPaCa-2 upon exposure to
crude extracts prompted us to elucidate the mechanism of action by
employing cell cycle analysis and MMP assay. The cytotoxic potential
of the extracts against MIAPaCa-2 was evaluated using BEZ-235
(0.01 μM) as a positive control and the untreated control cultures re-
ceived only the vehicle (DMSO b 0.5%).3.3.1. Cell cycle phase distribution
The cell cycle machinery interprets oncogenic signals and reﬂects
the biology of cancers.Cell cycle arrest is a common cause of growth inhibition. To deter-
mine whether the effect of extracts involve alterations in cell cycle pro-
gression, cell cycle distribution analysis was carried out using ﬂow
cytometry. The binding of water soluble, DNA intercalating propidium
iodide correlates with the amount of DNA within a given cell and the
relative content of DNA indicates the distribution of a population of
cells throughout the cell cycle. The effects of varying concentrations of
different crude extracts on cell cycle progression of PI stained
MIAPaCa-2 seeded cell line was analyzed by ﬂow cytometry. All four
tissue-speciﬁc extracts showed a concentration dependent increase in
the percentage of apoptotic cells. Moreover, SPL8 caused both apoptotic
cell death and S-phase arrest in increasing order at all the concentra-
tions used (Fig. 4L–N). The extract SPL5 (100 μg/ml) showed a signiﬁ-
cant effect (58.9%) on viability reduction compared to that of SPL6,
SPL7 and SPL8 which induced a considerable proportion of S-phase ar-
rest with a corresponding decrease in G1 and G2/M cell population
(Fig. 4C–N). The positive control BEZ-235 increased the apoptotic cell
population to 13.6% with S phase arrest of 20% (Fig. 4B). The lowest
IC50 against MIAPaCa-2 as well as the major reduction in cell viability
against 9.3% of vehicle treated cells (Fig. 4A) of the methanolic extract
of rhizome (SPL5)may be attributed towards the highest concentration
of its major chemical constituents viz. emodi and chrysophanol. The
hang-up of cell cycle succession might be one of the molecular events
connected with the selective anticancer efﬁcacy of the crude extract as
is shown by MIAPaCa-2 cell line.
3.3.2. Analysis of mitochondrial membrane potential (Δψm)
The mitochondrion plays an important role in the propagation of
apoptosis and is responsible for 90% of the energy needed by the cell.
The Δψm loss is an early event in mitochondrial mediated apoptosis.
To assesswhether the extracts affectmitochondrial integrity, the poten-
tial changes in mitochondrial membrane were analyzed by using
rhodamine-123, a dye indicatingΔψm loss (Pieme et al., 2013). Flow cy-
tometric analysis of MIAPaCa-2 cells after treatment with different con-
centrations of extracts for 48 h revealed a reduction in Δψm in a
concentration dependent manner. The SPL5, SPL6, and SPL7 caused
MMP loss from 11.6% in the case of untreated control (Fig. 5A) to amax-
imum of 42.3%, 37.1% and 26.6% respectively at a higher concentration
of 100 μg/ml (Fig. 5E, H, K). The maximum MMP loss of 24.4% in SPL8
was observed at a concentration of 50 μg/ml (Fig. 5M). The positive con-
trol BEZ-235 showed a 16.4% loss ofMMP (Fig. 5B). This loss is primarily
due to the activation of mitochondrial permeability transition (PT) pore
which leads to the consequent release of cytochrome C frommitochon-
dria and accordingly elicits other apoptotic factors to induce cell death.
In earlier studies it has been shown that permeability of inner mito-
chondrial membrane increases upon interaction of various anticancer
agents with the mitochondria (Wani et al., 2013). The results indicate
that extracts may be directly affecting the mitochondria to increase
membrane permeability and decrease Δψmwhich may further lead to
cell death (apoptosis/necrosis).
The plant parts and the extraction solvents greatly inﬂuence the an-
tiproliferative activity of the same plant species (Gul et al., 2013). As de-
scribed above, the concentrations of bioactive constituents varied
among the extracts screened for antiproliferative activity, and this
quantitative divergence is in correspondence with the percentage
growth inhibition of different cancer cell lines used. The extract SPL5
with a higher concentration of emodin and chrysophanol was found
to be highly active. This inference provides a way for the identiﬁcation
of elite chemotypes with better pharmacological signiﬁcance to ensure
their possible use as potential chemotherapeutic agents. Moreover, as
per the reports in the literature and the resultswe obtained, a possibility
of occurrence of synergism is plausible in the herbal extracts.
In conclusion, the overall results are indicative of the possible exis-
tence of a synergistic effect of crude extracts as they were found to be
more active than the individual chemical agents which may in all
probability bring-out the role of aglycone forms of major
Fig. 4. Flow cytometric analysis of human pancreatic cancer cell line (MIAPaCa-2). Cells were exposed to different concentrations (10, 50 and 100 μg/ml) of the extracts (SPL5, SPL6, SPL7
and SPL8) for 48 h and stained with PI (5 μg) to determine DNA ﬂuorescence and cell cycle phase distribution using FACS Aria II ﬂow cytometer. A) Negative control b 0.5%; B) positive
control (0.01 μM). The data are representative of three independent experiments.
Fig. 5. Effect of extracts on the integrity of mitochondrial membrane. TheMIAPaCa-2 cells were incubatedwith extracts (SPL5, SPL6, SPL7 and SPL8) at varying concentrations (10, 50 and
100 μg/ml) for 48 h. Thereafter, they were stained with rhodamine-123 (1 μM) for 1 h and analyzed in FACS Aria II ﬂow cytometer to determine the loss of mitochondrial membrane
potential (Δψm). A) Negative control (b0.5%); B) positive control (0.01 μM). The data are representative of three independent experiments.
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in inducing the death of cancer cells. Additionally, different plants
from varying altitudes presented signiﬁcant differences in the anthra-
quinone accumulation. It has a prospect of providing high yielding pop-
ulations of R. emodi for pharmacological and commercial utilization.
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